Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension
Launched by ALLERGAN · Sep 22, 2014
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -Diagnosis of either open-angle glaucoma or ocular hypertension in each eye and both eyes require IOP-lowering treatment.
- Exclusion Criteria:
- • Previous enrollment in another Allergan Bimatoprost SR Study.
- • Eye surgery (including cataract surgery) and/or any eye laser surgery within the past 6 months in the study eye
- • Anticipated need for laser eye surgery in either eye within the first 52 weeks of the study duration
- • History of glaucoma surgery
About Allergan
Allergan, a global leader in pharmaceutical innovation, specializes in developing and commercializing a diverse portfolio of advanced therapeutic and aesthetic products. With a commitment to improving the health and well-being of patients, Allergan conducts rigorous clinical trials to evaluate the safety and efficacy of its therapies across various medical fields, including ophthalmology, dermatology, and neuroscience. The company is dedicated to adhering to the highest ethical standards and regulatory guidelines, ensuring that its research not only advances medical science but also meets the needs of healthcare providers and patients worldwide. Through strategic collaborations and a focus on scientific excellence, Allergan continues to drive advancements in treatment options and enhance patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Cleveland, Ohio, United States
Indianapolis, Indiana, United States
Bronx, New York, United States
Haifa, , Israel
Zaragoza, , Spain
Morgantown, West Virginia, United States
Palo Alto, California, United States
Madrid, , Spain
Liege, , Belgium
New Orleans, Louisiana, United States
Dallas, Texas, United States
Haifa, , Israel
Glostrup, , Denmark
Stuart, Florida, United States
Houston, Texas, United States
Slingerlands, New York, United States
Hong Kong, , Hong Kong
San Francisco, California, United States
Irvine, California, United States
San Antonio, Texas, United States
Vienna, , Austria
Ashkelon, , Israel
Crystal River, Florida, United States
Zalaegerszeg, , Hungary
Chicago, Illinois, United States
Roswell, Georgia, United States
Glendale, California, United States
Kaohsiung, , Taiwan
Valladolid, , Spain
Rancho Cordova, California, United States
Rochester, New York, United States
Sevilla, , Spain
Nowy Targ, , Poland
Cordoba, , Spain
Chevy Chase, Maryland, United States
San Antonio, Texas, United States
Jacksonville, Florida, United States
Chesterfield, Missouri, United States
Hong Kong, , Hong Kong
Leuven, , Belgium
Phoenix, Arizona, United States
Makati, , Philippines
La Jolla, California, United States
Long Beach, California, United States
Los Angeles, California, United States
Montebello, California, United States
Pasadena, California, United States
Sacramento, California, United States
Colorado Springs, Colorado, United States
Atlantis, Florida, United States
Tampa, Florida, United States
Shawnee Mission, Kansas, United States
Quincy, Massachusetts, United States
Waltham, Massachusetts, United States
Bloomington, Minnesota, United States
Kansas City, Missouri, United States
South Orange, New Jersey, United States
Bethpage, New York, United States
New York, New York, United States
Rockville Centre, New York, United States
Asheville, North Carolina, United States
Elizabeth City, North Carolina, United States
Columbus, Ohio, United States
Eugene, Oregon, United States
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Florence, South Carolina, United States
Memphis, Tennessee, United States
Nashville, Tennessee, United States
Austin, Texas, United States
El Paso, Texas, United States
San Antonio, Texas, United States
Lynchburg, Virginia, United States
Chatsworth, , Australia
Fitzroy, , Australia
Glen Waverley, , Australia
Paramatta, , Australia
Preston, , Australia
Graz, , Austria
Goiania, Goias, Brazil
Belo Horizonte, Minas Gerais, Brazil
Campinas, Sao Paulo, Brazil
Osasco, Sao Paulo, Brazil
Rio Verde, , Brazil
Sao Paulo, , Brazil
Sao Paulo, , Brazil
Pecs, , Hungary
Szombathely, , Hungary
Haifa, , Israel
Lima, , Peru
Makati, , Philippines
Makati, , Philippines
Bydgoszcz, , Poland
Gdansk, , Poland
Lublin, , Poland
Olsztyn, , Poland
Warsaw, , Poland
Warsaw, , Poland
Warszawa, , Poland
Wroclaw, , Poland
Barcelona, , Spain
Barcelona, , Spain
Barcelona, , Spain
Madrid, , Spain
Valencia, , Spain
Hualien, , Taiwan
Patients applied
Trial Officials
Marina Bejanian
Study Director
Allergan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials